CHA Biotech, a Kosdaq-listed cell therapy company, said Tuesday that it has signed a contract development and manufacturing organization (CDMO) agreement with Frombio, a Kosdaq-listed health functional food company, to develop stem cell therapy for hair loss.Under the accord, CHA Biotech will establ
Tweet
